DBVT - DBV Technologies to Participate in Upcoming Investor Conferences | Benzinga
Montrouge, France, May 9, 2024
DBV Technologies to Participate in Upcoming Investor Conferences
DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, today announced Daniel Tassé, Chief Executive Officer, will deliver a company presentation at two investor conferences in May.
Citizens JMP Life Sciences Conference – May 13, 2024
Format: Fireside Chat
Time: 11:00am ET
Location: Hilton Midtown Hotel, New York, NY
H.C. Wainwright BioConnect Conference – May 20, 2024
Format: Fireside Chat
Time: 12:00pm ET
Location: NASDAQ World Headquarters, New York, NY
A live webcast of each presentation will be available on the Events page on the Investors section of the Company's website ...